Skip to main content
. 2023 Apr 18;12(4):613. doi: 10.3390/biology12040613

Figure 5.

Figure 5

Mutation assessment for ECT2 using the cBioPortal tool. (A) The alteration frequency with mutation type in a panel of analyzed human cancers. (B) A map representation for sites and types of ECT2 mutations. (C) The 3D structure of ECT2, with a highlight on the most altered site. (D) Assessment of the correlation between ECT2 mutation and disease-free, disease-specific, progression-free, and overall survival.